Literature DB >> 16978582

An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds.

H Howard Xu1, Lilian Real, Melissa Wu Bailey.   

Abstract

With the advancement of high throughput screening, it has become easier and faster to discover hit compounds that inhibit proliferation of bacterial cells. However, development in technologies used to identify cellular targets of potent antibacterial inhibitors has lagged behind. Here, we describe a novel strategy of target identification for antibacterial inhibitors using an array of Escherichia coli clones each over-expressing one essential protein. In a proof-of-concept study, eight essential genes were cloned into pLex5BA vector under the control of an inducible promoter. Over-expression of target proteins was confirmed. For two clones, one over-expressing FabI and the other over-expressing MurA enzymes, the host cells became 17- and 139-fold more resistant to the specific inhibitors triclosan and phosphomycin, respectively, while the susceptibility of other clones towards these inhibitors remained unchanged after induction of gene expression. Target identification via target protein over-expression was demonstrated using both mixed clone and individual clone assay formats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978582      PMCID: PMC3175528          DOI: 10.1016/j.bbrc.2006.08.166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

Review 1.  Development and spread of bacterial resistance to antimicrobial agents: an overview.

Authors:  F C Tenover
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

2.  Global transposon mutagenesis and a minimal Mycoplasma genome.

Authors:  C A Hutchison; S N Peterson; S R Gill; R T Cline; O White; C M Fraser; H O Smith; J C Venter
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

Review 3.  The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics.

Authors:  I Chopra; J Hodgson; B Metcalf; G Poste
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

5.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

6.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

Authors:  J C Butler; J Hofmann; M S Cetron; J A Elliott; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

7.  Complexes at the replication origin of Bacillus subtilis with homologous and heterologous DnaA protein.

Authors:  M Krause; B Rückert; R Lurz; W Messer
Journal:  J Mol Biol       Date:  1997-12-05       Impact factor: 5.469

8.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

9.  Role of embB in natural and acquired resistance to ethambutol in mycobacteria.

Authors:  F Alcaide; G E Pfyffer; A Telenti
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

10.  A genome-based approach for the identification of essential bacterial genes.

Authors:  F Arigoni; F Talabot; M Peitsch; M D Edgerton; E Meldrum; E Allet; R Fish; T Jamotte; M L Curchod; H Loferer
Journal:  Nat Biotechnol       Date:  1998-09       Impact factor: 54.908

View more
  11 in total

1.  Dual targeting antibacterial peptide inhibitor of early lipid A biosynthesis.

Authors:  Ronald J Jenkins; Garry D Dotson
Journal:  ACS Chem Biol       Date:  2012-04-27       Impact factor: 5.100

Review 2.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Authors:  Gaëlle Vandermeulen; Corinne Marie; Daniel Scherman; Véronique Préat
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

4.  A genome-wide inducible phenotypic screen identifies antisense RNA constructs silencing Escherichia coli essential genes.

Authors:  Jia Meng; Gregory Kanzaki; Diane Meas; Christopher K Lam; Heather Crummer; Justina Tain; H Howard Xu
Journal:  FEMS Microbiol Lett       Date:  2012-02-10       Impact factor: 2.742

5.  Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules.

Authors:  Poochit Nonejuie; Michael Burkart; Kit Pogliano; Joe Pogliano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

6.  Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin.

Authors:  Sanne H Olesen; Donna J Ingles; Yan Yang; Ernst Schönbrunn
Journal:  J Basic Microbiol       Date:  2013-05-20       Impact factor: 2.281

7.  Application of bacterial cytological profiling to crude natural product extracts reveals the antibacterial arsenal of Bacillus subtilis.

Authors:  Poochit Nonejuie; Rachelle M Trial; Gerald L Newton; Anne Lamsa; Varahenage Ranmali Perera; Julieta Aguilar; Wei-Ting Liu; Pieter C Dorrestein; Joe Pogliano; Kit Pogliano
Journal:  J Antibiot (Tokyo)       Date:  2015-12-09       Impact factor: 2.649

8.  Fatty acid synthesis in Escherichia coli and its applications towards the production of fatty acid based biofuels.

Authors:  Helge Jans Janßen; Alexander Steinbüchel
Journal:  Biotechnol Biofuels       Date:  2014-01-09       Impact factor: 6.040

9.  Advances in Non-Viral DNA Vectors for Gene Therapy.

Authors:  Cinnamon L Hardee; Lirio Milenka Arévalo-Soliz; Benjamin D Hornstein; Lynn Zechiedrich
Journal:  Genes (Basel)       Date:  2017-02-10       Impact factor: 4.096

10.  Plasmid selection in Escherichia coli using an endogenous essential gene marker.

Authors:  Shan Goh; Liam Good
Journal:  BMC Biotechnol       Date:  2008-08-11       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.